<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37352136</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>30</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>6</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Optineurin deficiency impairs autophagy to cause interferon beta overproduction and increased survival of mice following viral infection.</ArticleTitle><Pagination><StartPage>e0287545</StartPage><MedlinePgn>e0287545</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0287545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0287545</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Optineurin (OPTN) is associated with several human diseases, including amyotrophic lateral sclerosis (ALS), and is involved in various cellular processes, including autophagy. Optineurin regulates the expression of interferon beta (IFN&#x3b2;), which plays a central role in the innate immune response to viral infection. However, the role of optineurin in response to viral infection has not been fully clarified. It is known that optineurin-deficient cells produce more IFN&#x3b2; than wild-type cells following viral infection. In this study, we investigate the reasons for, and effects of, IFN&#x3b2; overproduction during optineurin deficiency both in vitro and in vivo.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">To investigate the mechanism of IFN&#x3b2; overproduction, viral nucleic acids in infected cells were quantified by RT-qPCR and the autophagic activity of optineurin-deficient cells was determined to understand the basis for the intracellular accumulation of viral nucleic acids. Moreover, viral infection experiments using optineurin-disrupted (Optn-KO) animals were performed with several viruses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">IFN&#x3b2; overproduction following viral infection was observed not only in several types of optineurin-deficient cell lines but also in Optn-KO mice and human ALS patient cells carrying mutations in OPTN. IFN&#x3b2; overproduction in Optn-KO cells was revealed to be caused by excessive accumulation of viral nucleic acids, which was a consequence of reduced autophagic activity caused by the loss of optineurin. Additionally, IFN&#x3b2; overproduction in Optn-KO mice suppressed viral proliferation, resulting in increased mouse survival following viral challenge.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings indicate that the combination of optineurin deficiency and viral infection leads to IFN&#x3b2; overproduction in vitro and in vivo. The effects of optineurin deficiency are elicited by viral infection, therefore, viral infection may be implicated in the development of optineurin-related diseases.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Fukushi et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fukushi</LastName><ForeName>Masaya</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-1315-2877</Identifier><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ohsawa</LastName><ForeName>Ryosuke</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okinaka</LastName><ForeName>Yasushi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima City, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oikawa</LastName><ForeName>Daisuke</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiyono</LastName><ForeName>Tohru</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Project for Prevention of HPV-related Cancer, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moriwaki</LastName><ForeName>Masaya</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Irie</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oda</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kamei</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0001-6382-1365</Identifier><AffiliationInfo><Affiliation>Spectrography and Bioimaging Facility, National Institute for Basic Biology, Okazaki, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tokunaga</LastName><ForeName>Fuminori</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3626-9119</Identifier><AffiliationInfo><Affiliation>Department of Medical Biochemistry, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sotomaru</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Natural Science Center for Basic Research and Development, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maruyama</LastName><ForeName>Hirofumi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Neuroscience &amp; Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kawakami</LastName><ForeName>Hideshi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Research Institute of Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sakaguchi</LastName><ForeName>Takemasa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3754-1252</Identifier><AffiliationInfo><Affiliation>Department of Virology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018797">Cell Cycle Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>77238-31-4</RegistryNumber><NameOfSubstance UI="D016899">Interferon-beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D035582">Transcription Factor TFIIIA</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C409460">OPTN protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C501288">Optn protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D026901">Membrane Transport Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018797" MajorTopicYN="Y">Cell Cycle Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016899" MajorTopicYN="N">Interferon-beta</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D035582" MajorTopicYN="N">Transcription Factor TFIIIA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014777" MajorTopicYN="Y">Virus Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026901" MajorTopicYN="Y">Membrane Transport Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>23</Day><Hour>13</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37352136</ArticleId><ArticleId IdType="pmc">PMC10289332</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0287545</ArticleId><ArticleId IdType="pii">PONE-D-23-07077</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Slowicka K, Vereecke L, van Loo G. Cellular Functions of Optineurin in Health and Disease. Trends Immunol. 2016;37(9):621&#x2013;33. Epub 20160730. doi: 10.1016/j.it.2016.07.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2016.07.002</ArticleId><ArticleId IdType="pubmed">27480243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan TA, Tumbarello DA. Optineurin: A Coordinator of Membrane-Associated Cargo Trafficking and Autophagy. Front Immunol. 2018;9:1024. Epub 2018/05/15. doi: 10.3389/fimmu.2018.01024 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01024</ArticleId><ArticleId IdType="pmc">PMC5962687</ArticleId><ArticleId IdType="pubmed">29867991</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying H, Yue BY. Cellular and molecular biology of optineurin. Int Rev Cell Mol Biol. 2012;294:223&#x2013;58. doi: 10.1016/B978-0-12-394305-7.00005-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-394305-7.00005-7</ArticleId><ArticleId IdType="pmc">PMC3673586</ArticleId><ArticleId IdType="pubmed">22364875</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al.. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465(7295):223&#x2013;6. Epub 2010/04/28. doi: 10.1038/nature08971 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Wu CJ, Zhao Y, Ashwell JD. Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP. Curr Biol. 2007;17(16):1438&#x2013;43. doi: 10.1016/j.cub.2007.07.041 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2007.07.041</ArticleId><ArticleId IdType="pubmed">17702576</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi T, Irie T, Kawabata R, Yoshida A, Maruyama H, Kawakami H. Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation. Neurosci Lett. 2011;505(3):279&#x2013;81. Epub 2011/10/21. doi: 10.1016/j.neulet.2011.10.040 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2011.10.040</ArticleId><ArticleId IdType="pubmed">22040667</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006;6(9):644&#x2013;58. doi: 10.1038/nri1900 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1900</ArticleId><ArticleId IdType="pubmed">16932750</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi T, Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol. 2002;14(1):111&#x2013;6. doi: 10.1016/s0952-7915(01)00305-3 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0952-7915(01)00305-3</ArticleId><ArticleId IdType="pubmed">11790540</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O&#x2019;Garra A. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15(2):87&#x2013;103. doi: 10.1038/nri3787 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankouri J, Fragkoudis R, Richards KH, Wetherill LF, Harris M, Kohl A, et al.. Optineurin negatively regulates the induction of IFNbeta in response to RNA virus infection. PLoS Pathog. 2010;6(2):e1000778. Epub 2010/02/19. doi: 10.1371/journal.ppat.1000778 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000778</ArticleId><ArticleId IdType="pmc">PMC2824764</ArticleId><ArticleId IdType="pubmed">20174559</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe9;nin P, Cuvelier F, Lambin S, C&#xf4;rte-Real Filipe J, Autrusseau E, Laurent C, et al.. Optineurin regulates the interferon response in a cell cycle-dependent manner. PLoS Pathog. 2015;11(4):e1004877. Epub 20150429. doi: 10.1371/journal.ppat.1004877 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004877</ArticleId><ArticleId IdType="pmc">PMC4414543</ArticleId><ArticleId IdType="pubmed">25923723</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Li H, Hong C, Chen M, Yue T, Chen C, et al.. ALS-Associated E478G Mutation in Human OPTN (Optineurin) Promotes Inflammation and Induces Neuronal Cell Death. Front Immunol. 2018;9:2647. Epub 20181114. doi: 10.3389/fimmu.2018.02647 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02647</ArticleId><ArticleId IdType="pmc">PMC6251386</ArticleId><ArticleId IdType="pubmed">30519240</ArticleId></ArticleIdList></Reference><Reference><Citation>Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013;13(10):722&#x2013;37. doi: 10.1038/nri3532 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3532</ArticleId><ArticleId IdType="pmc">PMC5340150</ArticleId><ArticleId IdType="pubmed">24064518</ArticleId></ArticleIdList></Reference><Reference><Citation>Bansal M, Moharir SC, Sailasree SP, Sirohi K, Sudhakar C, Sarathi DP, et al.. Optineurin promotes autophagosome formation by recruiting the autophagy-related Atg12-5-16L1 complex to phagophores containing the Wipi2 protein. J Biol Chem. 2018;293(1):132&#x2013;47. Epub 20171113. doi: 10.1074/jbc.M117.801944 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.801944</ArticleId><ArticleId IdType="pmc">PMC5766911</ArticleId><ArticleId IdType="pubmed">29133525</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell. 2011;147(4):728&#x2013;41. doi: 10.1016/j.cell.2011.10.026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.026</ArticleId><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine B, Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell. 2019;176(1&#x2013;2):11&#x2013;42. doi: 10.1016/j.cell.2018.09.048 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.09.048</ArticleId><ArticleId IdType="pmc">PMC6347410</ArticleId><ArticleId IdType="pubmed">30633901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al.. Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011;333(6039):228&#x2013;33. Epub 20110526. doi: 10.1126/science.1205405 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1205405</ArticleId><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, et al.. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell. 2007;131(6):1149&#x2013;63. doi: 10.1016/j.cell.2007.10.035 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.10.035</ArticleId><ArticleId IdType="pubmed">18083104</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaizuka T, Morishita H, Hama Y, Tsukamoto S, Matsui T, Toyota Y, et al.. An Autophagic Flux Probe that Releases an Internal Control. Mol Cell. 2016;64(4):835&#x2013;49. Epub 2016/11/03. doi: 10.1016/j.molcel.2016.09.037 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2016.09.037</ArticleId><ArticleId IdType="pubmed">27818143</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki R, Narisawa-Saito M, Yugawa T, Fujita M, Tashiro H, Katabuchi H, et al.. Oncogenic transformation of human ovarian surface epithelial cells with defined cellular oncogenes. Carcinogenesis. 2009;30(3):423&#x2013;31. Epub 2009/01/06. doi: 10.1093/carcin/bgp007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgp007</ArticleId><ArticleId IdType="pubmed">19126650</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurashige T, Kuramochi M, Ohsawa R, Yamashita Y, Shioi G, Morino H, et al.. Optineurin defects cause TDP43-pathology with autophagic vacuolar formation. Neurobiol Dis. 2021;148:105215. Epub 2020/12/06. doi: 10.1016/j.nbd.2020.105215 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105215</ArticleId><ArticleId IdType="pubmed">33296728</ArticleId></ArticleIdList></Reference><Reference><Citation>Taniguchi Y, Takeda S, Furutani-Seiki M, Kamei Y, Todo T, Sasado T, et al.. Generation of medaka gene knockout models by target-selected mutagenesis. Genome Biol. 2006;7(12):R116. doi: 10.1186/gb-2006-7-12-r116 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2006-7-12-r116</ArticleId><ArticleId IdType="pmc">PMC1794429</ArticleId><ArticleId IdType="pubmed">17156454</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa T, Kamei Y, Otozai S, Kim J, Sato A, Kuwahara Y, et al.. High-resolution melting curve analysis for rapid detection of mutations in a Medaka TILLING library. BMC Mol Biol. 2010;11:70. Epub 2010/09/15. doi: 10.1186/1471-2199-11-70 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2199-11-70</ArticleId><ArticleId IdType="pmc">PMC2949603</ArticleId><ArticleId IdType="pubmed">20840787</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushi M, Ito T, Oka T, Kitazawa T, Miyoshi-Akiyama T, Kirikae T, et al.. Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain. PLoS One. 2011;6(6):e21207. Epub 2011/06/20. doi: 10.1371/journal.pone.0021207 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0021207</ArticleId><ArticleId IdType="pmc">PMC3118813</ArticleId><ArticleId IdType="pubmed">21701593</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K. Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus. PLoS One. 2012;7(8):e42419. Epub 2012/08/01. doi: 10.1371/journal.pone.0042419 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0042419</ArticleId><ArticleId IdType="pmc">PMC3409853</ArticleId><ArticleId IdType="pubmed">22879974</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida A, Kawabata R, Honda T, Sakai K, Ami Y, Sakaguchi T, et al.. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes. J Virol. 2018;92(5). Epub 2018/02/12. doi: 10.1128/JVI.02094-17 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02094-17</ArticleId><ArticleId IdType="pmc">PMC5809723</ArticleId><ArticleId IdType="pubmed">29237838</ArticleId></ArticleIdList></Reference><Reference><Citation>Munitic I, Giardino Torchia ML, Meena NP, Zhu G, Li CC, Ashwell JD. Optineurin insufficiency impairs IRF3 but not NF-&#x3ba;B activation in immune cells. J Immunol. 2013;191(12):6231&#x2013;40. Epub 20131115. doi: 10.4049/jimmunol.1301696 .</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1301696</ArticleId><ArticleId IdType="pmc">PMC3886234</ArticleId><ArticleId IdType="pubmed">24244017</ArticleId></ArticleIdList></Reference><Reference><Citation>Meena NP, Zhu G, Mittelstadt PR, Giardino Torchia ML, Pourcelot M, Arnoult D, et al.. The TBK1-binding domain of optineurin promotes type I interferon responses. FEBS Lett. 2016;590(10):1498&#x2013;508. Epub 20160504. doi: 10.1002/1873-3468.12176 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1873-3468.12176</ArticleId><ArticleId IdType="pmc">PMC4879041</ArticleId><ArticleId IdType="pubmed">27086836</ArticleId></ArticleIdList></Reference><Reference><Citation>Slowicka K, Vereecke L, Mc Guire C, Sze M, Maelfait J, Kolpe A, et al.. Optineurin deficiency in mice is associated with increased sensitivity to Salmonella but does not affect proinflammatory NF-&#x3ba;B signaling. Eur J Immunol. 2016;46(4):971&#x2013;80. Epub 20160115. doi: 10.1002/eji.201545863 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201545863</ArticleId><ArticleId IdType="pubmed">26677802</ArticleId></ArticleIdList></Reference><Reference><Citation>Gleason CE, Ordureau A, Gourlay R, Arthur JSC, Cohen P. Polyubiquitin binding to optineurin is required for optimal activation of TANK-binding kinase 1 and production of interferon &#x3b2;. J Biol Chem. 2011;286(41):35663&#x2013;74. Epub 2011/08/23. doi: 10.1074/jbc.M111.267567 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.267567</ArticleId><ArticleId IdType="pmc">PMC3195586</ArticleId><ArticleId IdType="pubmed">21862579</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohd-Qawiem F, Nawal-Amani AR, Faranieyza-Afiqah F, Yasmin AR, Arshad SS, Norfitriah MS, et al.. Paramyxoviruses in rodents: A review. Open Vet J. 2022;12(6):868&#x2013;76. Epub 20221120. doi: 10.5455/OVJ.2022.v12.i6.14 .</Citation><ArticleIdList><ArticleId IdType="doi">10.5455/OVJ.2022.v12.i6.14</ArticleId><ArticleId IdType="pmc">PMC9805762</ArticleId><ArticleId IdType="pubmed">36650879</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka N, Sato M, Lamphier MS, Nozawa H, Oda E, Noguchi S, et al.. Type I interferons are essential mediators of apoptotic death in virally infected cells. Genes Cells. 1998;3(1):29&#x2013;37. doi: 10.1046/j.1365-2443.1998.00164.x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2443.1998.00164.x</ArticleId><ArticleId IdType="pubmed">9581980</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow YJ, Manel N. Aicardi-Gouti&#xe8;res syndrome and the type I interferonopathies. Nat Rev Immunol. 2015;15(7):429&#x2013;40. Epub 20150605. doi: 10.1038/nri3850 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3850</ArticleId><ArticleId IdType="pubmed">26052098</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang MA, Kim EK, Now H, Nguyen NT, Kim WJ, Yoo JY, et al.. Mutations in DDX58, which encodes RIG-I, cause atypical Singleton-Merten syndrome. Am J Hum Genet. 2015;96(2):266&#x2013;74. Epub 20150122. doi: 10.1016/j.ajhg.2014.11.019 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2014.11.019</ArticleId><ArticleId IdType="pmc">PMC4320253</ArticleId><ArticleId IdType="pubmed">25620203</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato H, Fujita T. RIG-I-like receptors and autoimmune diseases. Curr Opin Immunol. 2015;37:40&#x2013;5. doi: 10.1016/j.coi.2015.10.002 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2015.10.002</ArticleId><ArticleId IdType="pubmed">26530735</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene symbol: Tsp_14691. Available from: Tsp_14691 putative optineurin [Trichinella spiralis]&#x2014;Gene&#x2014;NCBI (nih.gov).</Citation></Reference><Reference><Citation>Gene symbol: LOC102631483. Available from: LOC102631483 optineurin [Citrus sinensis (sweet orange)]&#x2014;Gene&#x2014;NCBI (nih.gov).</Citation></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci. 2014;17(1):17&#x2013;23. Epub 2013/12/26. doi: 10.1038/nn.3584 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pmc">PMC4544832</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Haack TB, Ignatius E, Calvo-Garrido J, Iuso A, Isohanni P, Maffezzini C, et al.. Absence of the Autophagy Adaptor SQSTM1/p62 Causes Childhood-Onset Neurodegeneration with Ataxia, Dystonia, and Gaze Palsy. Am J Hum Genet. 2016;99(3):735&#x2013;43. Epub 2016/08/18. doi: 10.1016/j.ajhg.2016.06.026 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2016.06.026</ArticleId><ArticleId IdType="pmc">PMC5010644</ArticleId><ArticleId IdType="pubmed">27545679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al.. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science. 2015;347(6229):1436&#x2013;41. Epub 2015/02/19. doi: 10.1126/science.aaa3650 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, M&#xfc;ller K, et al.. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci. 2015;18(5):631&#x2013;6. Epub 2015/03/24. doi: 10.1038/nn.4000 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression. JAMA Neurol. 2017;74(12):1446&#x2013;54. doi: 10.1001/jamaneurol.2017.2255 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front Neurosci. 2019;13:1310. Epub 2019/12/06. doi: 10.3389/fnins.2019.01310 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue YC, Feuer R, Cashman N, Luo H. Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis? Front Mol Neurosci. 2018;11:63. Epub 2018/03/12. doi: 10.3389/fnmol.2018.00063 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00063</ArticleId><ArticleId IdType="pmc">PMC5857577</ArticleId><ArticleId IdType="pubmed">29593492</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>